We finally deploy UCAD for the ultrasensitive detection of anti-RBD IgG and IgM in clinical serum samples collected from a cohort of 85 kidney transplant receivers (KTRs) who received two doses of inactivated COVID-19 vaccine. The gene discussed is CD40LG; the disease is COVID-19.